Not applicableWithdrawnNCT04385524
What this trial is testing
Use of Dynavax Heplisav B in Healthcare Workers Previously Vaccinated With 3-dose Vaccine Who Failed to Demonstrate Seroprotection
Who this might be right for
Hepatitis B Virus
University of Louisville